The largest database of trusted experimental protocols

Hiseq 2000 sequencer

Manufactured by Illumina
Sourced in United States, China, Hong Kong, France, Germany, Australia, Denmark, Japan, Switzerland, Italy, Canada

The HiSeq 2000 is a high-throughput DNA sequencing system designed for large-scale genomic studies. It utilizes sequencing-by-synthesis technology to generate high-quality sequencing data. The HiSeq 2000 can produce up to 600 gigabases of data per run, making it suitable for a variety of applications, such as whole-genome sequencing, exome sequencing, and transcriptome analysis.

Automatically generated - may contain errors

919 protocols using hiseq 2000 sequencer

1

Illumina-based Sequencing Library Preparation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The sequencing library was prepared according to the standard protocol. Briefly, for mRNA sequencing, total RNA was firstly poly-A-selected followed by fragmentation of RNA into small pieces. The cleaved RNA fragments were reverse transcribed to cDNA end-repaired and ligated with Illumina adapters using Quick ligation TM kit (NEB) and DNA ligase. The libraries were then fractionated on agarose gel; 200-bp fragments were excised and amplified by PCR. After purification, the quality of libraries was checked by using Bioanalyzer 2100 (Agilent). MRNA sequencing was then performed on an Illumina HiSeq 2000 sequencer with 100 bp pair-end reads. For small RNA sequencing, libraries were prepared by ligating different adaptors to the total RNA followed by reverse transcription and PCR amplification. Small RNA libraries were sequenced on the Illumina HiSeq 2000 sequencer with 50 bp single-end reads, according to the standard manufacturer’s protocol. All raw data have been deposited in the NIH Short Read Archive database (SRP045645).
+ Open protocol
+ Expand
2

Whole-Exome Sequencing of Four Patients

Check if the same lab product or an alternative is used in the 5 most similar protocols
Four patients underwent whole-exome sequencing (WES, AROS Applied Biotechnology, Aarhus, Denmark) using the Illumina TruSeq exome capture kit and the Illumina HiSeq 2000 sequencer (Illumina Inc.). After hybridization and indexing, samples were pooled and 100bp paired end sequencing was performed (Illumina HiSeq 2000 sequencer). Reads were aligned to the hg19 human reference sequence (build GRCh37) using Novoalign version 2.08 (Novocraft, Selangor, Malaysia).
+ Open protocol
+ Expand
3

Stra8-KO Testis RNA-Seq Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was isolated using the Trizol reagent (Invitrogen; Cat#15596–018) from whole WT and Stra8-KO (Stra8-Cre;Upf2fl/Δ) testes at the age of 6 weeks in biological triplicates, followed by DNase I treatment and an additional purification using the RNeasy Mini Kit (Qiagen, Cat#74104). RNA integrity and quantity were determined using the Agilent 2100 Bioanalyzer. Total RNA (2μg) was used to generate sequencing libraries using the TruSeq RNA sample prep kit-v2 (Illumina, Cat#15027387) according to the manufacturer’s instructions, with a size selection between 350bp and 500bp and a PCR cycle number at 10. Barcoded libraries were pooled and sequenced using an Illumina HiSeq2000 sequencer (100bp paired-end reads). A summary of sequence reads from the RNA-Seq analyses was listed in S4 Table.
Total RNA was isolated from spermatocytes and round spermatids purified from a pool of 8 WT and 12 Stra8-KO (Stra8-Cre;Upf2fl/Δ) testes in duplicates at the age of 6 weeks using a Direct-zol RNA MiniPrep kit (Zymo, # R2050) with on-column DNase I treatment. RNA quality and quantity were assessed using the Agilent 2100 Bioanalyzer. Total RNA (1.5μg) was used to prepare the RNA-Seq libraries, which were then sequenced on an Illumina HiSeq2000 sequencer, as described above. A summary of sequence reads from the RNA-Seq analyses was listed in S5 Table.
+ Open protocol
+ Expand
4

RNA-seq Analysis of Colonic Epithelial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
RNA was isolated as described above. RNA-seq was performed by the Sequencing and Microarray Facility (SMF) core at MD Anderson. Libraries were generated using Illumina’s TruSeq kit and were sequenced using the Illumina HiSeq2000 Sequencer. Raw sequencing data (BCL format) were converted to Fastq files using Illumina Casava software (v1.8.2) and aligned to the mouse reference genome (mm10) using STAR software. The HTSeq-count program was used to generate raw read counts for each gene. The R package edgeR was used for data normalization and differential expression analysis using the criteria of log2 fold change ≥ 0.5 or ≤−0.5 and p value ≤ 0.1. Pathway enrichment analysis was performed using GSEA software based on p value from the aforementioned differential expression analysis, and clustering visualization was done by the R package heat map. To analyze YAP signature genes, the list of YAP signature genes 29 was obtained and formatted as the compatible pathway database (grp format) with GSEA. RNA from mouse colonic epithelial cells were isolated and sequenced using the Illumina HiSeq2000 Sequencer. In addition, we obtained a 92 IBD gene signature panel (common between the colons of ulcerative colitis and Crohn’s disease patients).
+ Open protocol
+ Expand
5

Illumina Deep Sequencing of Virus

Check if the same lab product or an alternative is used in the 5 most similar protocols
Deep sequencing of virus populations was performed using the Illumina HiSeq2000 sequencer with the sequencing kit, version 5. After removal of the four nucleotide bar codes used for multiplexing, more than 4 million single-end 76-nucleotide (nt) reads were obtained for each sample. Deep sequencing of selected virus mutants was performed with the Illumina HiSeq2000 sequencer using the HiSeq sequencing kit TruSeq v3. In these cases, more than 20 million paired-end 46-nt reads were obtained.
+ Open protocol
+ Expand
6

Targeted Sequencing for Hematological Malignancies

Check if the same lab product or an alternative is used in the 5 most similar protocols
As an orthogonal validation, all samples were concurrently sequenced by conventional bulk next-generation sequencing (bulk-seq) using target-capture deep sequencing (N = 111, median coverage: 421×, IQR: 319×–610×) or whole-exome sequencing (N = 12, median coverage: 150×, IQR: 86×–160×). Target-capture next-generation sequencing was performed using a SureSelect (Agilent Technologies) custom panel of 297 genes that are recurrently mutated in hematological malignancies (Supplementary Table 3). Briefly, genomic DNA was extracted using an Autopure extractor (QIAGEN/Gentra) and was fragmented and bait-captured in solution according to the manufacturer’s protocols. Captured DNA libraries were then sequenced using a HiSeq 2000 sequencer (Illumina) with 76-bp paired-end reads. Whole-exome sequencing was performed using SureSelect V4 exome probes (Agilent Technologies) and a HiSeq 2000 sequencer (Illumina) with 76-bp paired-end reads. Modified Mutect and Pindel algorithms were used for mutation calling12 (link).
+ Open protocol
+ Expand
7

Whole Genome and Exome Sequencing Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
For WGS datasets, two separate library preparation protocols were used. The gDNA libraries for full genome libraries were prepared using the reagents from a TrueSeq DNA Sample Prep Kit according to the manufacturer’s instructions (TrueSeq DNA Sample Preparation Guide, revision C; Illumina Inc., San Diego, CA) with minor modifications. After the ligation, the first protocol uses a gel-free method for samples instead of a gel step that was used for the second protocol. Furthermore, the number of PCR cycles in the PCR enrichment step differs between the two protocols (five and ten cycles, respectively). A High Sensitivity DNA chip (Agilent Technologies 2100; Santa Clara, CA) was used for quantification and samples were subsequently sequenced on an Illumina HiSeq 2000 sequencer at the same laboratory.
Libraries for the WES samples were prepared using the Agilent SureSelect Kit (Agilent Technologies, Santa Clara, CA), Nimblegen Capture Kit V2 or Nimblegen Capture Kit V3 (Roche NimbleGen Inc., Madison, WI), according to the manufacturer’s instructions. A High Sensitivity DNA chip (Agilent Technologies 2100) was used for the quantification and the samples were subsequently sequenced on an Illumina HiSeq 2000 sequencer at the same laboratory.
The library preparation and sequencing of all RNA-Seq samples are described elsewhere [23 (link),24 (link)].
+ Open protocol
+ Expand
8

Comprehensive Genomic and Transcriptomic Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total genomic DNA was extracted from leaf tissues using the DNeasy Plant Mini Kit (Qiagen, Valencia, CA, USA) according to the manufacturer's instructions. Total RNA was extracted from whole plants using the RNeasy Plant Mini Kit (Qiagen). For the small noncoding RNA library, total RNA was extracted from leaves using the mirVana Kit (Ambion, Austin, TX, USA). The quality of the RNA and DNA was checked on a Bioanalyzer 2100 (Agilent, Santa Clara, CA, USA). The libraries were prepared and sequenced according to the manufacturer's instructions (Illumina, San Diego, CA, USA). The DNA library was constructed using TruSeq DNA sample preparation kits and a single lane of an Illumina HiSeq2000 sequencer (PE, 2×101 bp). For the mRNA library, multiplex libraries were obtained using TruSeq RNA sample preparation kits, and the samples were sequenced in one lane of an Illumina HiSeq2000 sequencer (PE, 2×101 bp). The small RNA library was constructed using the TruSeq Small RNA Sample Prep Kit; the resulting single end library was sequenced in one lane of an Illumina GAIIX sequencer (SE, 1×35 bp). The files containing the sequences and quality scores of reads were deposited in the NCBI Short Read Archive, and the accession numbers are SRX465632 (genomic DNA-Seq), SRX465633 (mRNA-Seq), and SRX465634 (Small RNA-Seq).
+ Open protocol
+ Expand
9

Gene-based Association Study of Type 1 Diabetes

Check if the same lab product or an alternative is used in the 5 most similar protocols
The top T1 gene-based association identified in this study was followed up in two independent sample sets, RS (n=2,205 EAs) and ERF (n=1,254 EAs). For ERF, sequencing was done using the Agilent version V4 capture kit on an Illumina Hiseq2000 sequencer. In the RS, individuals were sequenced using the Nimblegen SeqCap EZ V2 capture kit on an Illumina Hiseq2000 sequencer. Details on sequencing, variant calling and variant quality control are provided in Supplemental Methods. Coding variants included in the analyses were defined as splicing, stop-gain, stop-loss, nonsynonymous, and indels. A gene-based T1 test was conducted as described above, with the significance threshold set at P<0.05.
+ Open protocol
+ Expand
10

Exome Sequencing of European Populations

Check if the same lab product or an alternative is used in the 5 most similar protocols
The exomes of 1336 individuals from the ERF study were sequenced at the Center for Biomics (Department of Cell Biology, Erasmus MC, Rotterdam, The Netherlands). Sequencing was performed at a mean depth of 74x (Agilent Technologies, Santa Clara, CA, USA, version 4 capture) on an Illumina Hiseq2000 sequencer using the TruSeq Version 3 protocol. After quality control we retrieved 543 954 high-quality single nucleotide variants (SNVs) in 1327 individuals. Individuals, whose exomes were not sequenced (N=1527) were genotyped on the Illumina Infinium HumanExome BeadChip, version 1.1. Calling was performed with GenomeStudio. In RS, exomes of 2628 randomly selected individuals from the RS-I population were sequenced at an average depth of 54 × (Nimblegen SeqCap EZ V2 capture) on an Illumina Hiseq2000 sequencer using the TrueSeq Version 3 protocol. The final dataset after quality control consisted of 600 806 SNVs among 2356 individuals, of which 1604 had CES-D data available. Details of sequencing and genotyping are provided in the supplement.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!